1. Updates on COVID-19 in Tokyo, Tokyo metropolitan government
https://stopcovid19.metro.tokyo.lg.jp/ Last accessed September 21, 2020.
2. Bureau of social welfare and public health, Tokyo metropolitan government https://www.fukushihoken.metro.tokyo.lg.jp/iryo/kansen/shibou.html Last accessed September 21, 2020.
3. American College of Surgeons. COVID-19 guidelines for triage of breast cancer patients. 2020. https://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancer Last accessed September 21, 2020..
4. Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat 2020;181(3):487-97. doi:10.1007/ s10549-020-05644-z
5. Japanese Breast cancer Society, The guidance for triage of breast cancer treatment in COVID -19. http://jbcs.gr.jp/member/wp-content/uploads/2020/06/triage20200624.pdf Last accessed September 21, 2020.
6. American Society of Plastic Surgeons. Statement on breast reconstruction in the face of COVID-19 pandemic. 2020. https://www.plasticsurgery.org/documents/medical-professionals/COVID19-Breast-Reconstruction-Statement.pdf. Last accessed September 21, 2020.
7. Specht M, Sobtiet N, Rosado N, Tomczyk E, Abbate O, Ellis D, et al. High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis. Breast Cancer Res Treat 2020; 182(3):679-88. doi: 10.1007/s10549-020-05739-7.
8. Lisa A, Battistini A, Giannasi S, Veronesi A, Bandi V, Maione L, et al. Breast Reconstruction in a Coronavirus Disease 2019 Hub. Plast Reconstr Surg Glob Open 2020;8(7):e3043.
doi:10.1097/GOX.0000000000003043
9. MacInnes EG, Piper J, Tait C, Waterworth A, Achuthan R, Hogan B, et al. Breast Cancer Surgery During the COVID-19 Pandemic Peak in the UK: Operative Outcomes. Cureus 2020;12(7): e9280. doi:10.7759/cureus.9280
10. Obeng-Gyasi S, Oppong B, Paskett ED, Lustberg M. Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?. Breast Cancer Res Treat 2020;182(3): 527-530. doi:10.1007/s10549-020-05740-0
11. Belkacemi Y, Grellier N, Ghith S, Debbi K, Coraggio G, Bounedjar A, et al. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer 2020;135: 130-46.doi: 10.1016/j.ejca.2020.05.015
12. Anwar SL, Harahap WA, Aryandono T. Perspectives on how to navigate cancer surgery in the breast, head and neck, skin, and soft tissue tumor in limited-resource countries during COVID-19 pandemic. Int J Surg 2020;79:206-12. doi:10.1016/j.ijsu.2020.05.072
13. Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020;18(4):452-78. doi:10.6004/jnccn.2020.0016
14. Spring LM, Gupta A, Reynolds KL, Gadd MA, Ellisen LW, Isakoff SJ, et al. Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. JAMA Oncol 2016;2(11):1477-86. doi:10.1001/jamaoncol.2016.1897
15. Alba E, Calvo L, Albanell J, De la Haba JR, Arcusa Lanza A, Chacon JI, et al. Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study. Ann Oncol 2012;23(12):3069-74. doi:10.1093/annonc/mds132
16. Semiglazov VF, Semiglazov VV, Dashyan GA, Ziltsova EK, Ivanov VG, Bozhok AA, et al. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer. Cancer 2007;110(2):244-54. doi:10.1002/cncr.22789
17. Eiermann W, Paepke S, Appfelstaedt J, Llombart-Cussac A, Eremin J, Vinholes J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann Oncol 2001;12(11):1527-32. doi:10.1023/a:1013128213451
18. Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, et al. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol 2017;35(10):1061-1069. doi:10.1200/JCO.2016.69.4406
19. Chetta MD, Schoenbrunner AR, Lee CN. Postmastectomy Breast Reconstruction in the Time of the Novel Coronavirus Disease 2019 (COVID-19) Pandemic. Plast Reconstr Surg Glob Open 2020;8(6):e2967. doi:10.1097/GOX.0000000000002967
20. Al-Hilli Z, Thomsen KM, Habermann EB, Jakub JW, Boughey JC. Reoperation for complications after lumpectomy and mastectomy for breast cancer from the 2012 National Surgical Quality Improvement Program (ACS-NSQIP). Ann Surg Oncol 2015;22(Suppl 3):S459–69.doi:10.1245/s10434-015-4741-7
21. Cavalcante FP, Novita GG, Millen EC, Zerwes FP, Oliveira VM, Sousa ALL, et al. Management of early breast cancer during the COVID-19 pandemic in Brazil. Breast Cancer Res Treat 2020;1-11. doi:10.1007/s10549-020-05877-y
22. Vanni G, Pellicciaro M, Materazzo M, Dauri M, D’angelillo RM, Buonomo C, et al. Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency. Breast Cancer 2020; 1-8.doi:10.1007/s12282-020-01137-5
23. Ahmed M . Optimizing breast cancer surgery during the COVID-19 pandemic. Breast Cancer 2020. doi:10.1007/s12282-020-01160-6